Alteplase as a catheter locking solution: In vitro evaluation of biochemical stability and antimicrobial properties

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 3, 2005, Pages 379-383

  Weck, Suzanne ^a   Cheung, Samantha ^a   Hiraoka Sutow, Martha ^a   Patapoff, Thomas ^a   Semba, Charles P ^a,b  

^a GENENTECH INC   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BENZYL ALCOHOL; WATER;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BLOOD CLOT LYSIS; BODY TEMPERATURE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STABILITY; DRUG STORAGE; ESCHERICHIA COLI; IN VITRO STUDY; MICROBIAL SENSITIVITY TEST; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 14844362472     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000148154.30967.27     Document Type: Article

References (25)

1. Freytes CO. Indications and complications of intravenous devices for chemotherapy. Curr Opin Oncol 2000; 12:303-307.
2. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them but can't live without them. Kidney Int 2000; 12:303-307.
3. Baumgartner JN, Cooper SL. Bacterial adhesion on polyurethane surfaces conditioned with thrombus components. ASAIO J 1996; 42:M476-M79.
4. Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath enhances central venous catheter infection. Crit Care Med 2002; 30:908-912.
5. Capdevila JA, Gavalda J, Fortea J, et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001; 7:7:206-212.
6. Stephens LC, Haire WD, Tarantolo S, et al. Normla saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells. Transfus Sci 1997; 18:187-193.
7. Hamilton RA, Plis JM, Clay C, Sylvan L. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices. Clin Pharm 1998; 7:439-443.
8. Meers C, Toffelmire EB. Tissue plasminogen activator efficacy in the restoration of hemodialysis catheter function. CANNT J 1999; 9:25-28.
9. Daeihagh P, Jordan J, Chen J, Rocco M. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 2000; 36:75-79.
10. Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming Quinton Permcath. Am J Kidney Dis 2000; 35:130-136.
11. Cathflo Activase [full prescribing information]. South San Francisco, CA: Genentech, Inc.
12. United States Pharmacopeial Convention. Rockville, MD: US Pharmacopeia, 2004. Available at: www.usp.org.
13. Jones AJ, Meunier AM. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 1990; 64:455-63.
14. Current Good Manufacturing Practice (CGMP) Regulations: Division of Manufacturing and Product Quality (HFD-320). Rockville, MD: US Food and Drug Administration, 2004. Available at: http://www.fda.gov/cder/dmpq/.
15. Parisi JT, Baldwin JN, Sottile M. Pour-plate method for the detection of coagulase production by Staphylococcus aureus. Appl Microbiol 1973; 25:558-561.
16. Little MA, Walshe JJ. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction. Am J Kidney Dis 2002; 39:86-91.
17. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol 1984; 19:687-693.
18. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-407.
19. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998; 22:945-947.
20. Stas KJ, Vanwalleghem J, Moor BD, Keuleers H. Trisodium citrate 30% versus heparin 5% as a catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent hemodialysis. Nephrol Dial Transplant 2001; 16:1521-1522.
21. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/cirpofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269-1278.
22. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14:427-432.
23. Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2002; 26:109-113.
24. FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant. FDA Talk Paper, April 14, 2000. Available at: http://www.fda.gov/bbs/topics/ANSWERS/ ANS01009.html. Accessed June 1, 2004.
25. Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982; 307:1384-1388.